Affiliation:
1. Schizophrenia Division; Complex Mental Illness Program; Centre for Addiction and Mental Health; Toronto ON Canada
2. Department of Psychiatry; University of Toronto; Toronto ON Canada
3. Department of Neuropsychiatry; Keio University School of Medicine; Tokyo Japan
4. Department of Psychiatry; Zucker Hillside Hospital; Northwell Health; Glen Oaks NY USA
5. Institute of Medical Science; University of Toronto; Toronto Canada
6. Department of Psychiatry; Hofstra Northwell School of Medicine; Hempstead NY USA
7. Campbell Family Mental Health Research Institute; Centre for Addiction and Mental Health; Toronto ON Canada
Funder
Canadian Institutes of Health Research (CIHR)
Roche
Sepracor Inc.
Sunovion
Boehringer Ingelheim
Neurocrine Biosciences
Pfizer, Inc.
Medicure and Neurocrine Bioscience
Laboratorios Farmacéuticos ROVI
Synchroneuron
Centre for Addiction and Mental Health (CAMH) Foundation
Japanese Society of Clinical Neuropsychopharmacology
Astellas Foundation for Research on Metabolic Disorders
Dainippon Sumitomo Pharma
Novartis
Eli Lilly & Company U.S., Eli Lilly Canada, Janssen-Ortho (Johnson & Johnson), Lundbeck, Mylan Pharmaceuticals, Novartis, Sepracor Inc., and Sunovion
Bristol-Myers Squibb
Otsuka
Subject
Psychiatry and Mental health
Reference26 articles.
1. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011;Hiemke;Pharmacopsychiatry,2011
2. Novartis Pharmaceuticals Canada Clozaril Product Monograph http://www.novartis.ca/asknovartispharma/download.htm?res=clozaril_scrip_e.pdf%26resTitleId=685
3. Novartis Pharmaceuticals USA Clozaril Product Monograph http://www.us.novartis.com/product/pi/pdf/Clozaril.pdf
4. The Brief Psychiatric Rating Scale;Overall;Psychol Rep,1962
5. Remission in schizophrenia: proposed criteria and rationale for consensus;Andreasen;Am J Psychiatry,2005
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献